These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20144195)

  • 41. HNF4alpha is a crucial modulator of the cholesterol-dependent regulation of NPC1L1.
    Iwayanagi Y; Takada T; Suzuki H
    Pharm Res; 2008 May; 25(5):1134-41. PubMed ID: 18080173
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transcriptional regulation of Niemann-Pick C1-like 1 gene by liver receptor homolog-1.
    Lee ES; Seo HJ; Back SS; Han SH; Jeong YJ; Lee JW; Choi SY; Han K
    BMB Rep; 2015 Sep; 48(9):513-8. PubMed ID: 25739390
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatic cholesterol transport from plasma into bile: implications for gallstone disease.
    Zanlungo S; Rigotti A; Nervi F
    Curr Opin Lipidol; 2004 Jun; 15(3):279-86. PubMed ID: 15166783
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The structure and function of Niemann-Pick C1-like 1 protein.
    Yu L
    Curr Opin Lipidol; 2008 Jun; 19(3):263-9. PubMed ID: 18460917
    [TBL] [Abstract][Full Text] [Related]  

  • 45. NPC1L1 (Niemann-Pick C1-like 1) mediates sterol-specific unidirectional transport of non-esterified cholesterol in McArdle-RH7777 hepatoma cells.
    Brown JM; Rudel LL; Yu L
    Biochem J; 2007 Sep; 406(2):273-83. PubMed ID: 17523925
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Effect of Polyphenols on Hypercholesterolemia through Inhibiting the Transport and Expression of Niemann-Pick C1-Like 1.
    Kobayashi S
    Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31590417
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cholesterol, non-cholesterol sterols and bile acids in paediatric gallstones.
    Koivusalo AI; Pakarinen MP; Sittiwet C; Gylling H; Miettinen TA; Miettinen TE; Nissinen MJ
    Dig Liver Dis; 2010 Jan; 42(1):61-6. PubMed ID: 19632165
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relevance of hereditary defects in lipid transport proteins for the pathogenesis of cholesterol gallstone disease.
    vanBerge-Henegouwen GP; Venneman NG; Portincasa P; Kosters A; van Erpecum KJ; Groen AK
    Scand J Gastroenterol Suppl; 2004; (241):60-9. PubMed ID: 15696852
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modulation of human Niemann-Pick C1-like 1 gene expression by sterol: Role of sterol regulatory element binding protein 2.
    Alrefai WA; Annaba F; Sarwar Z; Dwivedi A; Saksena S; Singla A; Dudeja PK; Gill RK
    Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G369-76. PubMed ID: 17008555
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bile acids and lipoprotein metabolism: effects of cholestyramine and chenodeoxycholic acid on human hepatic mRNA expression.
    Nilsson LM; Abrahamsson A; Sahlin S; Gustafsson U; Angelin B; Parini P; Einarsson C
    Biochem Biophys Res Commun; 2007 Jun; 357(3):707-11. PubMed ID: 17448444
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sterol carrier protein 2 participates in hypersecretion of biliary cholesterol during gallstone formation in genetically gallstone-susceptible mice.
    Fuchs M; Lammert F; Wang DQ; Paigen B; Carey MC; Cohen DE
    Biochem J; 1998 Nov; 336 ( Pt 1)(Pt 1):33-7. PubMed ID: 9806881
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nuclear receptors as potential molecular targets in cholesterol accumulation conditions: insights from evidence on hepatic cholesterol degradation and gallstone disease in humans.
    Bertolotti M; Gabbi C; Anzivino C; Carulli L; Loria P; Carulli N
    Curr Med Chem; 2008; 15(22):2271-84. PubMed ID: 18781949
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biliary lipid output and bile acid kinetics in cholesterol gallstone disease. Evidence for an increased hepatic secretion of cholesterol in Swedish patients.
    Nilsell K; Angelin B; Liljeqvist L; Einarsson K
    Gastroenterology; 1985 Aug; 89(2):287-93. PubMed ID: 4007420
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatic SR-BI, not endothelial lipase, expression determines biliary cholesterol secretion in mice.
    Wiersma H; Gatti A; Nijstad N; Kuipers F; Tietge UJ
    J Lipid Res; 2009 Aug; 50(8):1571-80. PubMed ID: 19252221
    [TBL] [Abstract][Full Text] [Related]  

  • 55. FMO3 and its metabolite TMAO contribute to the formation of gallstones.
    Chen Y; Weng Z; Liu Q; Shao W; Guo W; Chen C; Jiao L; Wang Q; Lu Q; Sun H; Gu A; Hu H; Jiang Z
    Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2576-2585. PubMed ID: 31251986
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Simultaneous determination of plasma mevalonate and 7alpha-hydroxy-4-cholesten-3-one levels in hyperlipoproteinemia: convenient indices for estimating hepatic defects of cholesterol and bile acid syntheses and biliary cholesterol supersaturation.
    Shoda J; Miyamoto J; Kano M; Ikegami T; Matsuzaki Y; Tanaka N; Osuga T; Miyazaki H
    Hepatology; 1997 Jan; 25(1):18-26. PubMed ID: 8985259
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transgenic overexpression of Niemann-Pick C2 protein promotes cholesterol gallstone formation in mice.
    Acuña M; González-Hódar L; Amigo L; Castro J; Morales MG; Cancino GI; Groen AK; Young J; Miquel JF; Zanlungo S
    J Hepatol; 2016 Feb; 64(2):361-369. PubMed ID: 26453970
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of the type of dietary fat on biliary lipid composition and bile lithogenicity in humans with cholesterol gallstone disease.
    Yago MD; González V; Serrano P; Calpena R; Martínez MA; Martínez-Victoria E; Mañas M
    Nutrition; 2005 Mar; 21(3):339-47. PubMed ID: 15797676
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activation of Constitutive Androstane Receptor Prevents Cholesterol Gallstone Formation.
    Cheng S; Zou M; Liu Q; Kuang J; Shen J; Pu S; Chen L; Li H; Wu T; Li R; Li Y; Jiang W; Zhang Z; He J
    Am J Pathol; 2017 Apr; 187(4):808-818. PubMed ID: 28283178
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic demonstration of intestinal NPC1L1 as a major determinant of hepatic cholesterol and blood atherogenic lipoprotein levels.
    Xie P; Zhu H; Jia L; Ma Y; Tang W; Wang Y; Xue B; Shi H; Yu L
    Atherosclerosis; 2014 Dec; 237(2):609-17. PubMed ID: 25463095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.